FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Tris Pharma infants* IBUPROFEN Recall

infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1

Tris Pharma Inc. · Monmouth Junction, NJ

Risk level
Class II
Reported by FDA
Dec 26, 2018
Recall ID
D-0335-2019
Check your lot numberHow we source this data

Summary

Tris Pharma recalled infants* IBUPROFEN starting Nov 26, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0335-2019 on Dec 26, 2018. Reason: Superpotent Drug: recalled lots may have higher concentration of ibuprofen. Status: Terminated.

Why it was recalled

Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Product description

infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-23, UPC 0 78742 02016 7.

Lot numbers, UPCs & expiration codes

Lot #: 00717009A, Exp 02/19; 00717015A, Exp 04/19; 00717024A, Exp 08/19

Where it was sold

One distributor in PA who further distributed Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0335-2019
Classification
Class II
Status
Terminated
Recall initiated
Nov 26, 2018
FDA report date
Dec 26, 2018
Quantity
164,304 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Tris Pharma Inc.

Original FDA data

Every field from FDA enforcement report D-0335-2019, exactly as published.

Show all FDA fields
City
Monmouth Junction
State
NJ
Status
Terminated
Country
United States
Event ID
81354
Address
2033 US Highway 130
Code information
Lot #: 00717009A, Exp 02/19; 00717015A, Exp 04/19; 00717024A, Exp 08/19
Postal code
08852-3003
Report date
Dec 26, 2018
Product type
Drugs
Recall number
D-0335-2019
Classification
Class II
Recalling firm
Tris Pharma Inc.
Product quantity
164,304 bottles
Termination date
Apr 1, 2021
Reason for recall
Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
Voluntary / mandated
Voluntary: Firm initiated
Product description
infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-23, UPC 0 78742 02016 7.
Distribution pattern
One distributor in PA who further distributed Nationwide in the USA.
Recall initiation date
Nov 26, 2018
Initial firm notification
Letter
Center classification date
Dec 17, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0335-2019, published Dec 26, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls